NCT03639610 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- units
- Participants
- groups
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 40 mg.
- id
- BG000
- title
- Cohort 1a, Melflufen 40 mg
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 30 mg.
- id
- BG001
- title
- Cohort 1b, Melflufen 30 mg
- description
- Patients with severe renal impairment (eGFR ≥15 to \<30 mL/min/1.73m²) and a starting dose of melflufen of 20 mg.
- id
- BG002
- title
- Cohort 2a, Melflufen 20 mg
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 52
- upper Limit
- 84
- value
- 70.0
- group Id
- BG001
- lower Limit
- 54
- upper Limit
- 85
- value
- 72.0
- group Id
- BG002
- lower Limit
- 57
- upper Limit
- 76
- value
- 62.5
- group Id
- BG003
- lower Limit
- 52
- upper Limit
- 85
- value
- 70.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 10
- title
- <65 years
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 14
- title
- ≥65 to ≤75 years
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 11
- title
- >75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 19
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 16
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 9
- title
- Czechia
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 10
- title
- Poland
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 147
- upper Limit
- 181
- value
- 165.0
- group Id
- BG001
- lower Limit
- 155
- upper Limit
- 189
- value
- 169.0
- group Id
- BG002
- lower Limit
- 167
- upper Limit
- 180
- value
- 172.5
- group Id
- BG003
- lower Limit
- 147
- upper Limit
- 189
- value
- 168.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 57.3
- upper Limit
- 132.0
- value
- 73.00
- group Id
- BG001
- lower Limit
- 54.0
- upper Limit
- 140.0
- value
- 75.25
- group Id
- BG002
- lower Limit
- 73.0
- upper Limit
- 110.0
- value
- 85.50
- group Id
- BG003
- lower Limit
- 54.0
- upper Limit
- 140.0
- value
- 74.00
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 17
- title
- score = 0
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 15
- title
- score = 1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- title
- score = 2
- description
- ECOG Performance Scale: 0=Normal activity, fully active, able to carry on all pre-disease performance without restriction. 1=Symptoms, but fully ambulatory, restricted in physically strenuous but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Eastern Cooperative Oncology Group (ECOG) score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- stage I
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 14
- title
- stage II
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 18
- title
- stage III
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- unknown
- description
- ISS Stage Stage I: Serum B2-microglobulin \<3.5 mg/L; serum albumin \>=3.5 g/dL Stage II: Not ISS Stage I or III. Stage III: Serum B2-microglobulin \>=5.5mg/L R-ISS Stage Stage I: ISS Stage I and standard risk chromosomal abnormalities (CA) by interphase by florescent in situ hybridization (iFISH) \& normal lactate dehydrogenase (LDH) Stage II: Not R-ISS Stage I or III Stage III: ISS Stage III \& either high risk CA by iFISH or high LDH
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (ISS) stage at study entry
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 29
- title
- Yes
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 6
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Evidence of lytic bone disease at study entry
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- title
- Yes
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 32
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Evidence of extramedullary disease at study entry
- unit Of Measure
- Participants
- population Description
- Baseline characteristics are shown for the Safety Analysis Set, which is defined as all patients who received at least 1 or partial dose of melflufen or dexamethasone.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- units
- Participants
- groups
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 40 mg.
- id
- BG000
- title
- Cohort 1a, Melflufen 40 mg
- description
- Patients with moderate renal impairment (eGFR ≥30 to \<45 mL/min/1.73m²) and a starting dose of melflufen of 30 mg.
- id
- BG001
- title
- Cohort 1b, Melflufen 30 mg
- description
- Patients with severe renal impairment (eGFR ≥15 to \<30 mL/min/1.73m²) and a starting dose of melflufen of 20 mg.
- id
- BG002
- title
- Cohort 2a, Melflufen 20 mg
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 52
- upper Limit
- 84
- value
- 70.0
- group Id
- BG001
- lower Limit
- 54
- upper Limit
- 85
- value
- 72.0
- group Id
- BG002
- lower Limit
- 57
- upper Limit
- 76
- value
- 62.5
- group Id
- BG003
- lower Limit
- 52
- upper Limit
- 85
- value
- 70.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 10
- title
- <65 years
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 14
- title
- ≥65 to ≤75 years
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 11
- title
- >75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 19
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 35
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 16
- title
- Greece
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 9
- title
- Czechia
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 10
- title
- Poland
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 147
- upper Limit
- 181
- value
- 165.0
- group Id
- BG001
- lower Limit
- 155
- upper Limit
- 189
- value
- 169.0
- group Id
- BG002
- lower Limit
- 167
- upper Limit
- 180
- value
- 172.5
- group Id
- BG003
- lower Limit
- 147
- upper Limit
- 189
- value
- 168.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 57.3
- upper Limit
- 132.0
- value
- 73.00
- group Id
- BG001
- lower Limit
- 54.0
- upper Limit
- 140.0
- value
- 75.25
- group Id
- BG002
- lower Limit
- 73.0
- upper Limit
- 110.0
- value
- 85.50
- group Id
- BG003
- lower Limit
- 54.0
- upper Limit
- 140.0
- value
- 74.00
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 17
- title
- score = 0
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 15
- title
- score = 1
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- title
- score = 2
- description
- ECOG Performance Scale: 0=Normal activity, fully active, able to carry on all pre-disease performance without restriction. 1=Symptoms, but fully ambulatory, restricted in physically strenuous but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Eastern Cooperative Oncology Group (ECOG) score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- stage I
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 14
- title
- stage II
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 18
- title
- stage III
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- unknown
- description
- ISS Stage Stage I: Serum B2-microglobulin \<3.5 mg/L; serum albumin \>=3.5 g/dL Stage II: Not ISS Stage I or III. Stage III: Serum B2-microglobulin \>=5.5mg/L R-ISS Stage Stage I: ISS Stage I and standard risk chromosomal abnormalities (CA) by interphase by florescent in situ hybridization (iFISH) \& normal lactate dehydrogenase (LDH) Stage II: Not R-ISS Stage I or III Stage III: ISS Stage III \& either high risk CA by iFISH or high LDH
- param Type
- COUNT_OF_PARTICIPANTS
- title
- International Staging System (ISS) stage at study entry
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 29
- title
- Yes
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 6
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Evidence of lytic bone disease at study entry
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- title
- Yes
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 32
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Evidence of extramedullary disease at study entry
- unit Of Measure
- Participants
- population Description
- Baseline characteristics are shown for the Safety Analysis Set, which is defined as all patients who received at least 1 or partial dose of melflufen or dexamethasone.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle